Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theratope vaccine for metastatic breast cancer
ISRCTN91516565Phase 3Completed
- Sponsor
- UK Co-ordinating Committee for Cancer Research
- Start
- Jan 2000
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised trial of Theratope STn-KLH vaccine in breast cancer (2 arms), sponsored by UK Co-ordinating Committee for Cancer Research. Started Jan 2000; status: completed.
02
Drugs
Theratope STn-KLH vaccine
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN91516565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91516565.